Lazard Asset Management
TNYA icon

Lazard Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

Lazard Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-77
Closed – – 2577
2024
Q4 		$0 Hold
77
– – ﹤0.01% 2540
2024
Q3 		$0 Sell
77
-140
-65% -$395 ﹤0.01% 2455
2024
Q2 		$0 Sell
217
-3,137
-94% -$13K ﹤0.01% 2429
2024
Q1 		$17K Sell
3,354
-1,853
-36% -$8.87K ﹤0.01% 1854
2023
Q4 		$16K Buy
5,207
+180
+4% +$389 ﹤0.01% 2072
2023
Q3 		$12K Buy
5,027
+232
+5% +$971 ﹤0.01% 2139
2023
Q2 		$27K Buy
4,795
+1,240
+35% +$7.21K ﹤0.01% 2044
2023
Q1 		$9K Sell
3,555
-90
-2% -$253 ﹤0.01% 2135
2022
Q4 		$7K Buy
+3,645
New +$8.9K ﹤0.01% 2238

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management's TNYA Position: Q1 2025 in Review

Lazard Asset Management sold out of Tenaya Therapeutics (TNYA) in Q1 2025, closing a stake of 77 shares.

Lazard Asset Management first reported a position in TNYA in Q4 2022 and held it in 9 quarters. The position peaked at $27K in Q2 2023. 107 funds tracked by Wall St. Rank hold TNYA as of Q1 2025.

  • Lazard Asset Management reported no remaining Tenaya Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 77 Tenaya Therapeutics shares in Q1 2025.
  • Lazard Asset Management first reported a position in Tenaya Therapeutics in Q4 2022 and held it in 9 quarters.
  • Lazard Asset Management's Tenaya Therapeutics position peaked at $27K in Q2 2023.
  • 107 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.